Dynavax Technologies Corp (DVAX)
11.83
+0.04
(+0.34%)
USD |
NASDAQ |
Nov 05, 10:36
Dynavax Technologies Price to Book Value: 2.412 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 04, 2024 | 2.403 |
November 01, 2024 | 2.401 |
October 31, 2024 | 2.416 |
October 30, 2024 | 2.458 |
October 29, 2024 | 2.408 |
October 28, 2024 | 2.322 |
October 25, 2024 | 2.183 |
October 24, 2024 | 2.196 |
October 23, 2024 | 2.216 |
October 22, 2024 | 2.240 |
October 21, 2024 | 2.238 |
October 18, 2024 | 2.232 |
October 17, 2024 | 2.226 |
October 16, 2024 | 2.248 |
October 15, 2024 | 2.193 |
October 14, 2024 | 2.132 |
October 11, 2024 | 2.126 |
October 10, 2024 | 2.096 |
October 09, 2024 | 2.159 |
October 08, 2024 | 2.167 |
October 07, 2024 | 2.196 |
October 04, 2024 | 2.246 |
October 03, 2024 | 2.281 |
October 02, 2024 | 2.314 |
October 01, 2024 | 2.304 |
Date | Value |
---|---|
September 30, 2024 | 2.271 |
September 27, 2024 | 2.242 |
September 26, 2024 | 2.212 |
September 25, 2024 | 2.196 |
September 24, 2024 | 2.216 |
September 23, 2024 | 2.265 |
September 20, 2024 | 2.314 |
September 19, 2024 | 2.344 |
September 18, 2024 | 2.285 |
September 17, 2024 | 2.295 |
September 16, 2024 | 2.273 |
September 13, 2024 | 2.277 |
September 12, 2024 | 2.236 |
September 11, 2024 | 2.224 |
September 10, 2024 | 2.281 |
September 09, 2024 | 2.216 |
September 06, 2024 | 2.248 |
September 05, 2024 | 2.212 |
September 04, 2024 | 2.214 |
September 03, 2024 | 2.218 |
August 30, 2024 | 2.287 |
August 29, 2024 | 2.295 |
August 28, 2024 | 2.244 |
August 27, 2024 | 2.285 |
August 26, 2024 | 2.324 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.049
Minimum
Aug 06 2024
83.73
Maximum
Jun 26 2020
11.45
Average
4.981
Median
Aug 05 2022
Price to Book Value Benchmarks
Biogen Inc | 1.557 |
Repligen Corp | 3.989 |
West Pharmaceutical Services Inc | 8.606 |
XOMA Royalty Corp | 3.539 |
Xencor Inc | 2.331 |
Price to Book Value Related Metrics
PE Ratio | 107.55 |
PS Ratio | 6.731 |
Price to Free Cash Flow | 47.57 |
Price | 11.83 |
Earnings Yield | 0.93% |
Market Cap | 1.550B |
Normalized PE Ratio | 112.80 |